Exact Mass: 476.1994
Exact Mass Matches: 476.1994
Found 416 metabolites which its exact mass value is equals to given mass value 476.1994
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-Methoxyestrone 3-glucuronide
2-Methoxyestrone 3-glucuronide belongs to the class of organic compounds known as steroid glucuronide conjugates. These are sterol lipids containing a glucuronide moiety linked to the steroid skeleton. Thus, 2-methoxyestrone 3-glucuronide is considered to be a steroid conjugate lipid molecule. 2-Methoxyestrone 3-glucuronide is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. 2-Methoxyestrone 3-glucuronide is a natural human metabolite of 2-methoxyestrone generated in the liver by UDP glucuronosyltransferase. 2-Methoxyestrone is a metabolite of 2-hydroxyestrone (a nonuterotrophic metabolite of estradiol). Glucuronidation is used to assist in the excretion of toxic substances, drugs, or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 2-Methoxyestrone 3-glucuronide is a natural human metabolite of 2-Methoxyestrone generated in the liver by UDP glucuonyltransferase. A glucuronide conjugate of 2-methodxyestrone formed by UDP-glucuronylstransferase (UTP). 2-methoxyestrone is a metabolite of 2-hydroxyestrone (a nonuterotrophic metabolite of estradiol) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Vemlidy
1-[1-(2,4-dihydroxyphenyl)-9-(2-dimethylaminoethyl)-2-hydroxy-2,3-dihydro-1H-3a-azacyclopenta[a]inden-1-yl]benzene-3,4,5-triol|yuremamine
9alpha-(2,3-epoxy-2-methylbutyryloxy)-divaricatolide-8-O-(2R,3R-epoxy-2-methylbutyrate)|9alpha-<2,3-epoxy-2-methylbutyryloxy>-divaricatolide-8-O-<2R,3R-epoxy-2-methylbutyrate>
cordyceamide B|N-benzoyl-L-tyrosinyl-L-p-hydroxyphenylalaninol acetate
9alpha-angeloyloxy-2alpha-hydroxy-divaricatolide-8-O-<2S,3S-epoxy-2-methylbutyrate>
(2R*,3S*,4R*,6R*,7R*,8R*,10R*,11R*,14S*)-3-angelyloxy-9-hydroxy-14-(3-hydroxy-3-methylbutanoyloxy)-14,15-epoxytrix-5(15)-en-4,12-olide
9beta-hydroxy-1beta,8beta-di-(2,3-epoxy-2-methylbutyryloxy)-6-epi-alpha-cyclocostunolide|9beta-hydroxy-1beta,8beta-di-<2,3-epoxy-2-methylbutyryloxy>-6-epi-alpha-cyclocostunolide
8beta-<5-(4,5-dihydroxytigloyloxy)-tigloyloxy>-nobilin
(S)-4-ethyl-4-hexanoyloxy-9-methoxy-1,12-dihydro-4H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione|20-Hexanoyl-10-methoxy-camptothecin|O-hexanoyl-10-methoxy-camptothecin
(2R,3R)-2,3-dihydro-3-hydroxymethyl-7-methoxy-2-(3-methoxy-4-alpha-L-rhamnopyranosyloxyphenyl)-5-benxofuranpropanol
10alpha-hydroxy-8beta-<5-(4-hydroxytigloyl)-4-hydroxytigloyloxy>-guaia-3,11(13)-dien-12,6alpha-olide|10alpha-hydroxy-8beta-[5-(4-hydroxytigloyl)-4-hydroxytigloyloxy]-guaia-3,11(13)-dien-12,6alpha-olide
3-desacetyl-5-(4-hydroxytigloyloxy)-eupaformosanin
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one
C26H28N4O5_1H-Imidazo[1,2-a]indole-9-propanoic acid, 2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-alpha-(4-oxo-3(4H)-quinazolinyl)-, methyl ester
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based: Match]
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based on: CCMSLIB00000845973]
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one_major
Ala His Ser Tyr
Ala His Tyr Ser
Ala Met Gln Gln
Ala Asn Ser Trp
Ala Asn Trp Ser
Ala Gln Met Gln
Ala Gln Gln Met
Ala Ser His Tyr
Ala Ser Asn Trp
Ala Ser Trp Asn
Ala Ser Tyr His
Ala Trp Asn Ser
Ala Trp Ser Asn
Ala Tyr His Ser
Ala Tyr Ser His
Cys Ile Asn Gln
Cys Ile Gln Asn
Cys Leu Asn Gln
Cys Leu Gln Asn
Cys Asn Ile Gln
Cys Asn Leu Gln
Cys Asn Gln Ile
Cys Asn Gln Leu
Cys Gln Ile Asn
Cys Gln Leu Asn
Cys Gln Asn Ile
Cys Gln Asn Leu
Cys Gln Gln Val
Cys Gln Val Gln
Cys Val Gln Gln
Glu Met Pro Thr
Glu Met Thr Pro
Glu Pro Met Thr
Glu Pro Thr Met
Glu Thr Met Pro
Glu Thr Pro Met
Phe His Ser Ser
Phe Ser His Ser
Phe Ser Ser His
Gly His Thr Tyr
Gly His Tyr Thr
Gly Asn Thr Trp
Gly Asn Trp Thr
Gly Gln Ser Trp
Gly Gln Trp Ser
Gly Ser Gln Trp
Gly Ser Trp Gln
Gly Thr His Tyr
Gly Thr Asn Trp
Gly Thr Trp Asn
Gly Thr Tyr His
Gly Trp Asn Thr
Gly Trp Gln Ser
Gly Trp Ser Gln
Gly Trp Thr Asn
Gly Tyr His Thr
Gly Tyr Thr His
His Ala Ser Tyr
His Ala Tyr Ser
His Phe Ser Ser
His Gly Thr Tyr
His Gly Tyr Thr
His Ser Ala Tyr
His Ser Phe Ser
His Ser Ser Phe
His Ser Tyr Ala
His Thr Gly Tyr
His Thr Tyr Gly
His Tyr Ala Ser
His Tyr Gly Thr
His Tyr Ser Ala
His Tyr Thr Gly
Ile Cys Asn Gln
Ile Cys Gln Asn
Ile Asn Cys Gln
Ile Asn Gln Cys
Ile Gln Cys Asn
Ile Gln Asn Cys
Leu Cys Asn Gln
Leu Cys Gln Asn
Leu Asn Cys Gln
Leu Asn Gln Cys
Leu Gln Cys Asn
Leu Gln Asn Cys
Met Ala Gln Gln
Met Glu Pro Thr
Met Glu Thr Pro
Met Asn Asn Val
Met Asn Val Asn
Met Pro Glu Thr
Met Pro Thr Glu
Met Gln Ala Gln
Met Gln Gln Ala
Met Thr Glu Pro
Met Thr Pro Glu
Met Val Asn Asn
Asn Ala Ser Trp
Asn Ala Trp Ser
Asn Cys Ile Gln
Asn Cys Leu Gln
Asn Cys Gln Ile
Asn Cys Gln Leu
Asn Gly Thr Trp
Asn Gly Trp Thr
Asn Ile Cys Gln
Asn Ile Gln Cys
Asn Leu Cys Gln
Asn Leu Gln Cys
Asn Met Asn Val
Asn Met Val Asn
Asn Asn Met Val
Asn Asn Val Met
Asn Gln Cys Ile
Asn Gln Cys Leu
Asn Gln Ile Cys
Asn Gln Leu Cys
Asn Ser Ala Trp
Asn Ser Trp Ala
Asn Thr Gly Trp
Asn Thr Trp Gly
Asn Val Met Asn
Asn Val Asn Met
Asn Trp Ala Ser
Asn Trp Gly Thr
Asn Trp Ser Ala
Asn Trp Thr Gly
Pro Glu Met Thr
Pro Glu Thr Met
Pro Met Glu Thr
Pro Met Thr Glu
Pro Thr Glu Met
Pro Thr Met Glu
Gln Ala Met Gln
Gln Ala Gln Met
Gln Cys Ile Asn
Gln Cys Leu Asn
Gln Cys Asn Ile
Gln Cys Asn Leu
Gln Cys Gln Val
Gln Cys Val Gln
Gln Gly Ser Trp
Gln Gly Trp Ser
Gln Ile Cys Asn
Gln Ile Asn Cys
Gln Leu Cys Asn
Gln Leu Asn Cys
Gln Met Ala Gln
Gln Met Gln Ala
Gln Asn Cys Ile
Gln Asn Cys Leu
Gln Asn Ile Cys
Gln Asn Leu Cys
Gln Gln Ala Met
Gln Gln Cys Val
Gln Gln Met Ala
Gln Gln Val Cys
Gln Ser Gly Trp
Gln Ser Trp Gly
Gln Val Cys Gln
Gln Val Gln Cys
Gln Trp Gly Ser
Gln Trp Ser Gly
Ser Ala His Tyr
Ser Ala Asn Trp
Ser Ala Trp Asn
Ser Ala Tyr His
Ser Phe His Ser
Ser Phe Ser His
Ser Gly Gln Trp
Ser Gly Trp Gln
Ser His Ala Tyr
Ser His Phe Ser
Ser His Ser Phe
Ser His Tyr Ala
Ser Asn Ala Trp
Ser Asn Trp Ala
Ser Gln Gly Trp
Ser Gln Trp Gly
Ser Ser Phe His
Ser Ser His Phe
Ser Trp Ala Asn
Ser Trp Gly Gln
Ser Trp Asn Ala
Ser Trp Gln Gly
Ser Tyr Ala His
Ser Tyr His Ala
Thr Glu Met Pro
Thr Glu Pro Met
Thr Gly His Tyr
Thr Gly Asn Trp
Thr Gly Trp Asn
Thr Gly Tyr His
Thr His Gly Tyr
Thr His Tyr Gly
Thr Met Glu Pro
Thr Met Pro Glu
Thr Asn Gly Trp
Thr Asn Trp Gly
Thr Pro Glu Met
Thr Pro Met Glu
Thr Trp Gly Asn
Thr Trp Asn Gly
Thr Tyr Gly His
Thr Tyr His Gly
Val Cys Gln Gln
Val Met Asn Asn
Val Asn Met Asn
Val Asn Asn Met
Val Gln Cys Gln
Val Gln Gln Cys
Trp Ala Asn Ser
Trp Ala Ser Asn
Trp Gly Asn Thr
Trp Gly Gln Ser
Trp Gly Ser Gln
Trp Gly Thr Asn
Trp Asn Ala Ser
Trp Asn Gly Thr
Trp Asn Ser Ala
Trp Asn Thr Gly
Trp Gln Gly Ser
Trp Gln Ser Gly
Trp Ser Ala Asn
Trp Ser Gly Gln
Trp Ser Asn Ala
Trp Ser Gln Gly
Trp Thr Gly Asn
Trp Thr Asn Gly
Tyr Ala His Ser
Tyr Ala Ser His
Tyr Gly His Thr
Tyr Gly Thr His
Tyr His Ala Ser
Tyr His Gly Thr
Tyr His Ser Ala
Tyr His Thr Gly
Tyr Ser Ala His
Tyr Ser His Ala
Tyr Thr Gly His
Tyr Thr His Gly
ST 19:4;O3;GlcA
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Tenofovir alafenamide
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
1H-Pyrazolo(4,3-d)pyrimidine-3-carboxamide, 1-(2-ethoxyethyl)-5-(ethylmethylamino)-7-((4-methyl-2-pyridinyl)amino)-N-(methylsulfonyl)
Gutolactone
A quassinoid isolated from Simaba guianensis and has been shown to exhibit antimalarial activity.
METHYLDOPA SESQUIHYDRATE
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
4-methoxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronic acid
Norcaesalpinin D
A diterpenoid isolated from the seed kernels of Caesalpinia crista that has been found to exhibit antimalarial activity.
N-[(Z)-3-[3-(dimethylamino)propylamino]-1-[5-(3-nitrophenyl)furan-2-yl]-3-oxoprop-1-en-2-yl]-4-methylbenzamide
Ethyl 3-(2-chlorophenyl)-3-[(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)amino]propanoate
1-[(3,4-Dimethoxyphenyl)-[1-(thiophen-2-ylmethyl)-5-tetrazolyl]methyl]-4-phenylpiperazine
N-(2-adamantyl)-4-(4-ethylsulfonyl-1-piperazinyl)-3-nitrobenzamide
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-(4-ethoxyphenyl)-N-[(E)-(4-propan-2-yloxyphenyl)methylideneamino]triazole-4-carboxamide
1-[[1-(1,3-Benzodioxol-5-ylmethyl)-5-tetrazolyl]-(2-fluorophenyl)methyl]-4-(2-furanylmethyl)piperazine
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
2-[(2R,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3R,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
2-[(2S,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2S,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2S,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-methoxyestrone 3-O-(beta-D-glucuronide)
A steroid glucosiduronic acid that is 2-methoxyestrone having a single beta-D-glucuronic acid residue attached at position 3.
MT-7716 hydrochloride
MT-7716 hydrochloride (W-212393 hydrochloride) is a selective non-peptide nociceptin receptor (NOP) agonist and promising potential treatment drug for alcohol abuse and relapse prevention[1].
(1s,4ar,5s,6r,6as,11as,11bs)-1,6-bis(acetyloxy)-4a-hydroxy-4,4,11b-trimethyl-7-oxo-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
4,5,17-trihydroxy-6,14,18-trimethyl-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-12-yl 3-methylbut-2-enoate
(1r,4ar,6r,7s,7ar)-7-hydroxy-4,7-bis(hydroxymethyl)-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl (3s)-3-methylpentanoate
1,7-bis(4-hydroxyphenyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-3-one
(1s,4as,6s,7r,7as)-6,7-dihydroxy-4-(hydroxymethyl)-7-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl (3s)-3-methylpentanoate
2-(hydroxymethyl)-6-({3,11,17-trihydroxytricyclo[12.3.1.1²,⁶]nonadeca-1(18),2(19),3,5,14,16-hexaen-9-yl}oxy)oxane-3,4,5-triol
(1r,4ar,6r,7s,7ar)-7-hydroxy-4,7-bis(hydroxymethyl)-6-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl (3s)-3-methylpentanoate
6-(2,3-dimethyloxirane-2-carbonyloxy)-5-hydroxy-5a,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl 2,3-dimethyloxirane-2-carboxylate
(1r,5r,6s,8s,9s,10s,13s,14r,15s)-8-hydroxy-5-{[(2r,3s)-3-hydroxy-2-methylbutanoyl]oxy}-10-methyl-11-oxo-4,12-dioxapentacyclo[7.7.0.0¹,⁶.0²,¹³.0¹⁰,¹⁵]hexadec-2-en-14-yl (2z)-2-methylbut-2-enoate
(3as,4s,5s,5ar,6s,7s,9as,9bs)-6,7-dihydroxy-5a,9-dimethyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(3as,4s,5s,5ar,6s,7s,9as,9bs)-6,7-dihydroxy-5a,9-dimethyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl (2r,3r)-2,3-dimethyloxirane-2-carboxylate
1β-hydroxyleudesma- 4, 11-dien-3-one
{"Ingredient_id": "HBIN002415","Ingredient_name": "1\u03b2-hydroxyleudesma- 4, 11-dien-3-one","Alias": "NA","Ingredient_formula": "C25H32O9","Ingredient_Smile": "CC1=CC(C(C2(C1C(C3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)OC(=O)C=C(C)C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41911","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}